Clin2
NCT07479277Possibly a fitRecruiting

Progel to reduce air leaks after lung surgery

Non-Small Cell Lung CancerPostoperative Air LeakNSCLC

Part of Cancer, Lungs & breathing clinical trials.

This trial tests whether a special gel (Progel Platinum) can reduce air leaks that sometimes happen after lung cancer surgery. It is for people having minimally invasive surgery to remove the upper or lower lobe of the lung.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
160 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You are 18 years or older and willing to give written consent.
  • You need surgery to remove one of the upper or lower lobes of your lung using a minimally invasive (VATS) approach.
  • The surgery must not be on the middle lobe of the right lung.
  • You cannot have had radiation or chemo before this surgery.
  • You do not have severe COPD (GOLD stage 3 or worse).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04875585Recruiting· Phase 2
Neoadjuvant and post-surgery immunotherapy for operable lung cancer

This trial tests a combination of medicines given before surgery and immunotherapy after surgery for resectable non-small cell lung cancer (NSCLC). It aims to shrink the tumor before the operation and reduce the risk of cancer coming back after surgery.

Innsbruck, Tyrol
NCT05061550Recruiting· Phase 2
Targeted immune-plus-chemo treatment before and after lung surgery

This trial studies whether adding immune treatment and chemotherapy around the time of lung tumor removal improves outcomes for people with operable non-small cell lung cancer (NSCLC). You may qualify if your cancer can be surgically removed and your tumor tests meet required biomarker rules.

Little Rock, Arkansas
NCT06467617Recruiting· Phase 2
Immunotherapy and chemo before and after lung cancer surgery

This trial tests a combination of an immunotherapy drug (adebrelimab) plus chemotherapy and another drug (recaticimab) before and after surgery for people with stage II or III lung cancer that can be removed. The goal is to see if this approach helps shrink tumors and improves outcomes.

Beijing, Beijing Municipality
NCT04772287Not yet recruiting· Phase 3
Study drug after lung surgery for EGFR/ALK-negative lung cancer

This phase 3 trial tests adding toripalimab (an immunotherapy) to standard chemotherapy after surgery for certain stage II to IIIB (N2) lung cancers. It aims to lower the chance the cancer comes back by treating tiny remaining cancer cells and supporting your immune system.

NCT07350265Recruiting
Testing a lung surgery technique to reduce air leaks

This study tests a special ventilation method during lung surgery to see if it can predict air leaks after the procedure. If successful, it could help patients recover more smoothly after a lobectomy or segmentectomy.

Antony
NCT06597604Not yet recruiting
Testing TenaTac® glue to prevent air leaks after lung surgery

This study tests whether a new medical glue called TenaTac® can safely prevent air leaks after lung surgery. You may be eligible if you're scheduled for a lobectomy and your surgeon plans to use a special glue.

Metz, Grand Est

Hear when a new Non Small Cell Lung Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.